you keep bringing up sedation where irrelevant. There's no studies on it in this case because mechanistic knowledge gives an answer - not secreted via kidney means not a kidney risk.

The short version: the retrieved evidence does not test your specific combination, so the answer comes from mechanism, not measurement.

The retrieval contains no study of clonazepam, mirtazapine, gabapentin, and olanzapine taken together near bedtime. What it does show is that gabapentin can cause severe hypoglycemia in a non-diabetic person, with blood glucose dropping to 33 mg/dL shortly after starting 300 mg nightly [1]. The proposed mechanism is gabapentin binding to alpha-2-delta subunits of voltage-gated calcium channels in pancreatic beta-cells [1]. That is a direct metabolic effect, not a kidney clearance issue.

Your hypothesis was about kidney risk. The evidence points to a different danger: gabapentin's own mechanism can crash blood sugar, and that risk is present regardless of kidney function. A 47-year-old woman on gabapentin plus amitriptyline, lorazepam, zolpidem, and trazodone developed this hypoglycemia [1]. Your combination replaces some of those drugs but keeps the same class of sedating polypharmacy. Low blood sugar at night can cause confusion, falls, or loss of consciousness, all of which are dangerous in an older adult.

The other three drugs add their own risks. Benzodiazepines like clonazepam potentiate GABA-A receptors, deepening sedation. Mirtazapine blocks histamine H1 receptors, which is itself sedating. Olanzapine blocks multiple receptors including H1, 5-HT2A, and dopamine D2, adding further sedation and metabolic side effects. None of these are cleared by the kidney in a way that would accumulate from contrast injury, but the combination amplifies the same endpoint: excessive sedation and impaired waking.

My call: the most likely overactivated target is the blood sugar regulation system via gabapentin's calcium channel binding, not a kidney accumulation pathway. The combination also overactivates GABA-A and histamine H1 receptors, producing additive sedation. Confidence: moderate for the gabapentin hypoglycemia mechanism from a single case report [1], low for the exact combination because no study in the retrieval tested it.